ArticleInternational ophthalmology2026
Predictive value of a phenylephrine-guided resection algorithm in optimizing eyelid symmetry following bilateral Müller Muscle-Conjunctival Resection.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Müller muscle-conjunctival resection in modern ptosis surgery: patient selection, technical refinements, and expanding indications.Frontiers in surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the anatomical, functional, and aesthetic outcomes of phenylephrine-guided bilateral Müller muscle-conjunctival resection (MMCR) using a standardized resection algorithm designed to optimize eyelid symmetry by preoperatively accounting for Hering's phenomenon in patients with mild-to-moderate ptosis
methodsThis retrospective clinical study included patients with good levator function and a positive phenylephrine test who underwent simultaneous bilateral MMCR planned according to a phenylephrine-based resection algorithm. The protocol aimed to simulate postoperative eyelid position and unmask contralateral ptosis related to Hering's law, thereby enabling individualized bilateral surgical planning in a single session. Preoperative and postoperative best-corrected visual acuity (BCVA), margin reflex distance1 (MRD-1) and upper eyelid symmetry were evaluated at postoperative months 1 and 3
resultsA total of 118 eyes from 59 patients (31 females, 28 males) were included. The mean preoperative MRD-1 was 1.24 ± 0.95 mm in the right eye and 1.32 ± 0.84 mm in the left eye. At postoperative month 3, the mean MRD-1 increased to 2.68 ± 0.91 and 2.61 ± 0.78, respectively. Comparison of preoperative and postoperative MRD-1 values demonstrated demonstrated a statistically significant improvement in both eyes at months 1 and 3 (p < 0.001 for each eye). Postoperative MRD-1 outcomes were not significantly different when stratified by the magnitude of the preoperative phenylephrine response (p = 0.32 for right eye, p = 0.06 for left eye). Excellent eyelid symmetry was achieved in 44 patients (74.6%), satisfactory symmetry in 12 (20.3%), and poor symmetry in 3 patients (5.0%). Revision surgery was required in 5 patients (8.4%) during follow-up
conclusionPhenylephrine-guided bilateral MMCR using a standardized resection algorithm is a safe, effective, and highly predictable surgical approach for achieving optimal eyelid symmetry in patients with mild-to-moderate ptosis. Preoperative simulation of postoperative eyelid position by accounting for Hering's phenomenon allows accurate bilateral surgical planning in a single session and may reduce the need for secondary procedures, making this technique a strong first-line alternative to more invasive ptosis repair methods.
Indexed as
Identifiers
41701404What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.